isoxazoles has been researched along with Anti-MuSK Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Deng, J; Feng, H; Liu, W; Luo, Y; Ou, C; Qiu, L | 1 |
| Apostolski, S; Bartlett, RR; Damjanovic, M; Isakovic, K; Kosec, D; Vidic-Dankovic, B | 1 |
2 other study(ies) available for isoxazoles and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Leflunomide treatment in corticosteroid-dependent myasthenia gravis: an open-label pilot study.
Topics: Activities of Daily Living; Adolescent; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Myasthenia Gravis; Pilot Projects; Prednisone; Treatment Outcome; Young Adult | 2016 |
Leflunomide prevents the development of experimentally induced myasthenia gravis.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Female; Flow Cytometry; Immunization; Immunosuppressive Agents; Isoxazoles; Leflunomide; Myasthenia Gravis; Rats; Rats, Inbred Strains; Receptors, Cholinergic; T-Lymphocyte Subsets; Thymus Gland; Time Factors; Torpedo | 1995 |